Hjem › Prostatakræft › Texas › Sugar Land
Prostatakræft kliniske forsøg i Sugar Land, TX
4 studier for Prostatakræft søger deltagere på steder i og omkring Sugar Land (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekruttererFase 3
- MD Anderson in Sugar Land, Sugar Land
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekruttererFase 3
- Houston Methodist Sugar Land Hospital, Sugar Land
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RekruttererFase 3
- MD Anderson in Sugar Land, Sugar Land
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekruttererFase 3
- MD Anderson in Sugar Land, Sugar Land
Prostatakræft forsøg i andre byer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN42 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andre studier i Sugar Land
- Overvægt11 studier
- Overvægt10 studier
- Ikke-småcellet lungecancer8 studier
- Brystkræft7 studier
- Forstyrrelser med overdreven søvnighed7 studier
- Steatotisk leversygdom6 studier
- Lungecancer6 studier
- Atopisk dermatitis (eczem)6 studier
- Type 2-diabetes5 studier
- Søvnforstyrrelser5 studier
- Metastatisk cancer4 studier
- Pneumokokinfektioner4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.